Arch Pediatr

1. LEQUENNE A, Gascoin G, Brehin C, Jouanolou C, et al
   Knowledge of maternity caregivers on vaccination BCG recommendations and circuits.
   Arch Pediatr. 2026;33:105546.
   

   >> Share

   
   

   
   Arch Virol

2. WANG L, Yang X, Zhang B, Hao S, et al
   Construction and evaluation of a recombinant duck enteritis virus expressing the envelope protein of duck Tembusu virus in ducks.
   Arch Virol. 2025;170:153.
   

   >> Share

   
   

   
   BMC Pediatr

3. ALHUSAINI W, Sanyour G, Kutbi R, Alhusaini Y, et al
   Disseminated BCGosis in immunocompromised infants: a five-case series in the context of a national BCG vaccination policy change.
   BMC Pediatr. 2026 Jun 23. doi: 10.1186/s12887-026-07174.
   

   >> Share

   
   
4. JIAO Y, Li Q, Chen Z, Yang L, et al
   Severe combined immunodeficiency with BCG-osis by salvage therapy with allogeneic hematopoietic stem cell transplantation: cases report and literature review.
   BMC Pediatr. 2025;25:768.
   

   >> Share

   
   

   
   BMJ

5. MAHASE E
   HPV jab: cervical cancer deaths fall to zero in vaccinated young women, research shows.
   BMJ. 2026;393:e100047.
   

   >> Share

   
   

   
   J Immunol

6. CHAN AKP, Baumgarth N, Griffin DE
   Single-cell profiling of immune activation, dysregulation, and reconstitution in rhesus macaques after measles virus infection.
   J Immunol. 2026;215:vkag139.
   

   >> Share

   
   
7. XIA JY, Zhao L, Li YY, Wei XF, et al
   Computational and experimental mapping of antigenic epitopes on iridovirus major capsid protein for precision vaccine design.
   J Immunol. 2026;215:vkag159.
   

   >> Share

   
   
8. STURTZ AJ, Evavold BK, Heidari Rarani Z, Alsoussi WB, et al
   BPTF is essential for vaccine-induced germinal center B cell responses.
   J Immunol. 2026;215:vkag126.
   

   >> Share

   
   

   
   J Infect Dis

9. LI J, Liu M, Li J, Zhou Y, et al
   Correlates of human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development.
   J Infect Dis. 2026 Jun 23:jiag317. doi: 10.1093.
   

   >> Share

   
   

   
   JAMA

10. ROTHMAN JM, Kwan B, Jena AB
    Trends in Newborn Hepatitis B Virus Vaccination-Reply.
    JAMA. 2026 Jun 22. doi: 10.1001/jama.2026.6524.
    

    >> Share

    
    
11. DYSART K, Ruan AB, Burris HH
    Trends in Newborn Hepatitis B Virus Vaccination.
    JAMA. 2026 Jun 22. doi: 10.1001/jama.2026.6521.
    

    >> Share

    
    

    
    Nat Immunol

12. 
    Diversifying the antibody response to influenza virus with an mRNA-based vaccine.
    Nat Immunol. 2026 Jun 23. doi: 10.1038/s41590-026-02565.
    

    >> Share

    
    
13. HAUPT S, Cottrell CA, Zhou X, Lee JH, et al
    Rapid boosting increases germinal center responses to sequential vaccines.
    Nat Immunol. 2026 Jun 23. doi: 10.1038/s41590-026-02549.
    

    >> Share

    
    
14. WANG B, Chen L, Tagliabue A, Ulmer J, et al
    From vaccinology to immunology and back: progress and challenges.
    Nat Immunol. 2026 Jun 22. doi: 10.1038/s41590-026-02543.
    

    >> Share

    
    

    
    Nat Med

15. O'LEARY K
    HPV vaccination linked to dramatic reduction in cervical cancer deaths.
    Nat Med. 2026 Jun 25. doi: 10.1038/d41591-026-00033.
    

    >> Share

    
    

    
    Pediatrics

16. ARCHER HI, Watson A, Liao LD, Jacobson KB, et al
    Concordance Between Maternal and Infant COVID-19 and Influenza Vaccination Status.
    Pediatrics. 2026 Jun 24:e2025075163. doi: 10.1542/peds.2025-075163.
    

    >> Share

    
    
17. BRYAN MA, Mihalek AJ, Torres R, Desai S, et al
    Barriers and Facilitators of Inpatient Vaccine Delivery at US Children's Hospitals: A Qualitative Study.
    Pediatrics. 2026 Jun 24:e2025075278. doi: 10.1542/peds.2025-075278.
    

    >> Share

    
    

    
    PLoS Comput Biol

18. NUISMER SL, Remien CH, Ghersi B, Nichols J, et al
    Evaluating vectors for the design of a spillover-disrupting Lassa virus transmissible vaccine.
    PLoS Comput Biol. 2026;22:e1014390.
    

    >> Share

    
    

    
    PLoS Med

19. HAGAN JE
    The well-worn path from armed conflict to measles resurgence.
    PLoS Med. 2026;23:e1005156.
    

    >> Share

    
    

    
    PLoS One

20. DA SILVA MARQUES M, de Neri Machado F, Amaral Mali M, da Costa Sarmento N, et al
    Case-control study of risk factors for abscess development following hepatitis B vaccination in children in Timor-Leste, 2024.
    PLoS One. 2026;21:e0351879.
    

    >> Share

    
    
21. MARTINS A, Bosco Santos MF, Nascimento J, da Silva Chui FM, et al
    Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic.
    PLoS One. 2026;21:e0351566.
    

    >> Share

    
    
22. DEMEKE AD, Tsegaye A, Bayable A, Tamir T, et al
    An umbrella review navigating the nationwide burden of hepatitis B virus infection in Ethiopia: A call for action on vaccination, safe blood, and infection prevention.
    PLoS One. 2026;21:e0352169.
    

    >> Share

    
    
23. SABER MA, Shovon MHJ, Imtiaz M, Tauhida SJ, et al
    Pan-genome and reverse vaccinology for a multi-epitope vaccine against circulating post-2022 Monkeypox virus strains.
    PLoS One. 2026;21:e0351881.
    

    >> Share

    
    
24. MUTISYA F, Agogo GO, Opudo J, Jepkorir B, et al
    Pneumococcal conjugate vaccine effectiveness against hypoxemia in children with suspected pneumonia in Kenya; analysis from a real-world sentinel surveillance platform.
    PLoS One. 2026;21:e0351500.
    

    >> Share

    
    

    
    Vaccine

25. TANI N, Sato T, Goto T, Harada Y, et al
    Longitudinal changes in the antibody responses and adverse reactions across successive SARS-CoV-2 mRNA vaccinations from the primary series to the JN.1-adapted booster in hospital employees: A 4-year prospective cohort study.
    Vaccine. 2026;89:128887.
    

    >> Share

    
    
26. MAGNUSSON AC, Lim S, Niemi C, Wolf N, et al
    Intranasal influenza vaccination using an outer membrane vesicle platform.
    Vaccine. 2026;89:128876.
    

    >> Share

    
    
27. WANG WJ, Zhu Q, Zhi YX, Huang MM, et al
    Updates on the research on nanocarriers in fish vaccine oral, immersion and injection delivery: A major review.
    Vaccine. 2026;88:128873.
    

    >> Share

    
    
28. SINGER D, La EM, Dubois de Gennes C, Graham J, et al
    Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease.
    Vaccine. 2026;88:128770.
    

    >> Share

    
    
29. SHINJOH M, Furuichi M, Sugimoto R, Kawakami C, et al
    Effectiveness of inactivated and live-attenuated influenza vaccines in children during the 2025-2026 influenza season with genetically distinct influenza A and B viruses.
    Vaccine. 2026;88:128869.
    

    >> Share

    
    
30. ONG MM, van den Biggelaar AHJ, Goh L, Hutton H, et al
    Safety and immunogenicity of a genetically inactivated stand-alone acellular pertussis vaccine as a booster to Australian adults: a randomized, controlled, non-inferiority trial.
    Vaccine. 2026;88:128863.
    

    >> Share

    
    
31. YANG H, Gao X, Zhang R, Pei C, et al
    Personal vs professional HPV vaccination and screening among female healthcare workers in China.
    Vaccine. 2026;88:128879.
    

    >> Share

    
    
32. GONDWE KW, Hearst MO, Mbutuka HR, Khwepeya M, et al
    Factors associated with COVID-19 vaccine acceptance among refugee women at Dzaleka refugee camp in Malawi.
    Vaccine. 2026;88:128862.
    

    >> Share

    
    
33. COUTO MONIZ M, Luo S, Krokhin A, Egorov A, et al
    Purified gamma-irradiated influenza A vaccine demonstrates high immunogenicity and protection against a drifted H1N1 strain.
    Vaccine. 2026;88:128872.
    

    >> Share

    
    
34. CHEN S, Hupert N, Bento AI
    Vaccine coverage and quarantine during a school-based measles outbreak, South Carolina, USA, 2025-2026.
    Vaccine. 2026;88:128860.
    

    >> Share

    
    
35. FLEMING JA, Colistro V, Knudson S, Colomar M, et al
    Timing and frequency of antenatal care visits in relation to maternal respiratory syncytial virus vaccine opportunities in four Latin American countries.
    Vaccine. 2026;88:128854.
    

    >> Share

    
    
36. GUAGLIARDO SAJ, Major CG, Rodriguez DM, Rivera-Amill V, et al
    Cross-sectional analysis of chikungunya vaccine acceptability among residents of Ponce, Puerto Rico, 2024-2025.
    Vaccine. 2026;88:128845.
    

    >> Share

    
    
37. CHEN S, Fang Y, Yu FY, Ding L, et al
    Systematic review and meta-analysis of digital seasonal influenza vaccination promotion in people aged >/=50 ?years.
    Vaccine. 2026;88:128865.
    

    >> Share

    
    
38. WANG L, Li Z, Zhu H, Jia X, et al
    Bivalent foot-and-mouth disease virus mRNA vaccine induces well-balanced humoral and cellular immune responses.
    Vaccine. 2026;88:128840.
    

    >> Share

    
    
39. RUNGPRASERT K, Areeraksakul P, Tunterak W, Prakairungnamthip D, et al
    Immunogenicity and protective efficacy of an inactivated cluster 2.1 duck Tembusu virus vaccine in ducks: Evidence of cross-genotype immune responses.
    Vaccine. 2026;88:128867.
    

    >> Share

    
    
40. HENKES NC, Heien HC, Inselman JW, Farraye FA, et al
    Outcomes in adult liver transplant patients receiving recombinant herpes zoster vaccine.
    Vaccine. 2026;88:128859.
    

    >> Share

    
    
41. TORKAMAN-ASADI F, Bakhtiari S, Safarzadeh M, Riahi-Rad Z, et al
    Clinical outcomes among SARS-CoV-2 omicron-infected adults according to prior infection and vaccination history in Iran: A retrospective registry-based study.
    Vaccine. 2026;88:128868.
    

    >> Share

    
    
42. JAMWAL S, Omene B, Giri A, Rojas K, et al
    Half a century of pneumococcal vaccination in sickle cell disease: Are we winning the battle or losing immunity?
    Vaccine. 2026;88:128866.
    

    >> Share

    
    
43. LEVATI E, Calvani R, Cacciatore S, Tosato M, et al
    Influenza, pneumococcal, and herpes zoster vaccination in Italy: Knowledge, uptake, and determinants across the adult life course.
    Vaccine. 2026;88:128853.
    

    >> Share

    
    
44. NTUMNGIA FB, Kolli SK, Howard GP, Subramani PA, et al
    Evaluation of immunogenicity and efficacy of a Plasmodium vivax nanoparticle vaccine in mice.
    Vaccine. 2026;88:128857.
    

    >> Share

    
    
45. MORIO R, Takazono T, Morimoto S, Ashizawa N, et al
    Comparison of immunogenicity of mRNA and protein subunit SARS-CoV-2 vaccines in dialysis patients: a multicenter study.
    Vaccine. 2026;88:128861.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share